Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000138

EVP Research and Development gave up 466 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

STAHL NEIL · EVP Research and Development

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-09 Shares withheld for taxes : show line 1 in the form −466 $787.00 $366,742 49,133 D
Loading xslF345X05/edgardoc.xml…